Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says

A groundbreaking study reveals that lung cancer patients in stage 4, who hadn't experienced metastasis, saw significantly extended survival rates when they underwent lung transplants. Historically, these patients weren't considered for organ transplants due to their advanced cancer stage, but this research suggests a new, life-saving possibility. The findings are not just a medical breakthrough; they also raise ethical questions about prioritizing patients for transplants and redefining what we consider "curable" in advanced cancer cases. This could reshape future treatment guidelines and patient selection criteria.